Manufacturer record
Sun Pharma Laboratories Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Sun Pharma Laboratories Ltd (Sikkim) were declared Not of Standard Quality between February 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SIH0304A, Clopidogrel and Aspirin Capsules (exp Nov 2027). FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra State (state lab) found it not of standard quality: The Sample does not Comply for description, as- the Capsule Containing Lumps of Multi-Coloured granules. Listed in the September 2026 alert.
Records by type
11 records linked to Sun Pharma Laboratories Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Clopidogrel and Aspirin Capsules | Batch SIH0304AMfg Feb 2026 · Exp Nov 2027 | The Sample does not Comply for description, as- the Capsule Containing Lumps of Multi-Coloured granulesDescription | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab | Sep 2026 |
| Rifaximin Tablets (Rifagut 400) | Batch GKE0938 AMfg Jun 2023 · Exp May 2025 | Not applicableOther | Not applicableState lab | Apr 2024 |
| Levetiracetam Tablets IP (Levipil 500) | Batch SIE1003AMfg Apr 2023 · Exp Mar 2025 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2024 |
| Rosuvastatin Tablets IP (Rosuvas 10 Tablets) | Batch SID3056AMfg Nov 2022 · Exp Apr 2025 | Description and Assay of Rosuvastatin Calcium calculated as RosuvastatinAssay | RDTL ChandigarhState lab | Jul 2023 |
| Montek LC (Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP) | Batch SIC3283AMfg Dec 2021 · Exp May 2024 | Identification & Assay of Montelukast Sodium & Assay of Levocetirizine HydrochlorideAssay | CDL KolkataCDSCO lab | Feb 2023 |
| Pan -D (Pantoprazole Gastro-Resistant and Domperidone Prolonged Release Capsules IP) | Batch 22442611Mfg Sep 2022 · Exp Aug 2024 | Identification and AssayAssay | CDL KolkataCDSCO lab | Jan 2023 |
| Montek� LC (Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP) | Batch SIC1932AMfg Aug 2021 · Exp Jan 2024 | Identification and Assay of MontelukastAssay | RDTL GuwahatiState lab | Oct 2022 |
| Pantoprazole Gastro Resistant and Domperidone Prolonged-Release Capsules IP | Batch RPB0651AMfg Jan 2021 · Exp Dec 2022 | Identification and AssayAssay | RDTL GuwahatiState lab | Apr 2022 |
| Rosuvas� F-5 (Rosuvastatin and Fenofibrate Tablets I.P.) | Batch EMU2687Mfg Sep 2019 · Exp Feb 2022 | Dissolution of FenofibrateDissolution | CDL KolkataCDSCO lab | May 2021 |
| Rosuvas 20 (Rosuvastatin Tablets I.P.) | Batch EMX0685Mfg Mar 2020 · Exp Aug 2023 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | May 2021 |
| Rosuvas 20 (Rosuvastatin Tablets I.P.) | Batch EMX0174Mfg Jan 2020 · Exp Jun 2022 | Uniformity of Weight, Dissolution and AssayAssay | CDL KolkataCDSCO lab | Feb 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.